26
Views
7
CrossRef citations to date
0
Altmetric
Review

Critical appraisal of IFN-α-based adjuvant therapy in Stage II–III malignant melanoma

Pages 563-569 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vincent G Brichard & Diane Lejeune. (2008) Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease. Expert Opinion on Biological Therapy 8:7, pages 951-968.
Read now

Articles from other publishers (6)

Qian Zhao, Renxia Zhang, Caixia Qiao, Ying Miao, Yukang Yuan & Hui Zheng. (2023) Ubiquitination network in the type I IFN‐induced antiviral signaling pathway. European Journal of Immunology.
Crossref
Gaurav D. Shah & Paul B. Chapman. (2007) Adjuvant Therapy of Melanoma. The Cancer Journal 13:3, pages 217-222.
Crossref
Zoya R. Yurkovetsky, John M. Kirkwood, Howard D. Edington, Adele M. Marrangoni, Lyudmila Velikokhatnaya, Matthew T. Winans, Elieser Gorelik & Anna E. Lokshin. (2007) Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b. Clinical Cancer Research 13:8, pages 2422-2428.
Crossref
. 2007. Color Atlas of Melanocytic Lesions of the Skin. Color Atlas of Melanocytic Lesions of the Skin 237 259 .
Serge Y. Fuchs. (2005) De-regulation of ubiquitin-dependent proteolysis and the pathogenesis of malignant melanoma. Cancer and Metastasis Reviews 24:2, pages 329-338.
Crossref
L. Kretschmer, I. Beckmann, K.M. Thoms, H. Haenssle, H.P. Bertsch & Ch. Neumann. (2005) Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas. European Journal of Cancer 41:4, pages 531-538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.